Recordati, IT0003828271

Recordati stock costs EUR 52.98 with volume 86.7 percent below average

Published on 10/12/2026 at 14:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Recordati stock costs EUR 52.98 on October 12, 2026. Volume is 86.7 percent below the 329,881-share average, while the 52-week high is EUR 55.35.

Key points in brief

  • Recordati stock was EUR 52.98 at Lang & Schwarz on October 12, 2026 at 2:33 p.m. CEST.
  • Trading volume was 43,957 shares versus a 329,881-share average.
  • The stock stood 4.3 percent below its EUR 55.35 52-week high.
  • Recordati had a EUR 10.8 billion market capitalization and a P/E ratio of 22.3.
Architektur-Render eines modernen Glas-Bürogebäudes mit grüner Außenanlage
Recordati S.p.A. (IT0003828271) könnte in einem solchen modernen Glas-Bürohochhaus mit begrünter Plaza ansässig sein, Illustration mit AI erstellt.

Recordati stock was trading at EUR 52.98 at Lang & Schwarz on October 12, 2026 at 2:33 p.m. CEST. The bid was EUR 52.95 and the ask was EUR 53.00, giving investors a narrow intraday spread to monitor.

Volume remains below average

Trading volume stood at 43,957 shares at the latest finance quote, compared with an average of 329,881 shares. That puts turnover 86.7 percent below the average, making liquidity a central feature of the session rather than a price-direction signal.

Stock stays below yearly high

Recordati's 52-week range runs from EUR 43.76 to EUR 55.35. At EUR 52.98, the stock was 4.3 percent below the high and 21.1 percent above the low, placing it in the upper part of its annual range.

The quote showed a market capitalization of EUR 10.8 billion and a P/E ratio of 22.3 on October 12, 2026. The valuation is also close to the EUR 53.00 bid level described in the takeover coverage, leaving the offer process as an important calendar factor for the stock.

Valuation and next reporting date

In first half 2026, Recordati reported revenue of EUR 1.4 billion, up 6.6 percent, while adjusted net income rose 6.7 percent to EUR 350.0 million, according to Yahoo Finance. The next scheduled reporting date is November 10, 2026, when the company is listed as due to release third-quarter results by MarketScreener.

On October 6, 2026, Finimize reported that the acceptance period for the takeover offer had been extended to October 23, with cash payment scheduled for November 2. Il Sole 24 ORE reported on October 6 that Banca Akros kept a EUR 65.00 target, while Equita cited EUR 69.00.

Comparison with peers

Recordati: P/E 22.3, market capitalization EUR 10.8 billion

Sanofi (Euronext Paris, EUR): plus 0.9 percent, P/E 22.3, market capitalization EUR 86.6 billion

Ipsen (Euronext Paris, EUR): plus 0.9 percent, P/E 23.3, market capitalization EUR 11.9 billion

Next reporting date is November 10

The next reporting date gives the market a defined checkpoint after the offer timetable. Until then, the key numerical markers are the EUR 52.98 quote, the EUR 55.35 yearly high, the EUR 10.8 billion market value and turnover at 13.3 percent of its average.

Recordati was trading at EUR 52.98 at Lang & Schwarz on October 12, 2026 at 2:33 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Recordati stock.

Recordati stock facts

  • Company: Recordati Industria Chimica e Farmaceutica S.p.A.
  • ISIN: IT0003828271
  • Ticker: REC.MI
  • Primary exchange: Borsa Italiana
  • Price Lang & Schwarz as of October 12, 2026, 2:33 p.m. CEST: EUR 52.98
  • Market capitalization: EUR 10.8 billion as of October 12, 2026
  • 52-week range: EUR 43.76-EUR 55.35 as of October 12, 2026
  • Sector / Industry: Healthcare / Medical Pharmaceuticals
  • Index membership: FTSE MIB
  • Next earnings date: November 10, 2026

Market context: Market report FTSE MIB.

More news and analyses on Recordati stock

Disclaimer...

en | IT0003828271 | RECORDATI | boerse | 70302622 | bgmi